These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 29263662)
1. Selenium-coated nanostructured lipid carriers used for oral delivery of berberine to accomplish a synergic hypoglycemic effect. Yin J; Hou Y; Yin Y; Song X Int J Nanomedicine; 2017; 12():8671-8680. PubMed ID: 29263662 [TBL] [Abstract][Full Text] [Related]
2. Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis. Deng J; Wu Z; Zhao Z; Wu C; Yuan M; Su Z; Wang Y; Wang Z Int J Nanomedicine; 2020; 15():3937-3951. PubMed ID: 32581538 [TBL] [Abstract][Full Text] [Related]
3. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery. Li H; Chen M; Su Z; Sun M; Ping Q Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421 [TBL] [Abstract][Full Text] [Related]
4. Mixed Micelles with Galactose Ligands for the Oral Delivery of Berberine to Enhance Its Bioavailability and Hypoglycemic Effects. Kang H; Yao Y; Zhang X J Biomed Nanotechnol; 2020 Dec; 16(12):1755-1764. PubMed ID: 33485402 [TBL] [Abstract][Full Text] [Related]
5. Effect of cell-penetrating peptide-coated nanostructured lipid carriers on the oral absorption of tripterine. Chen Y; Yuan L; Zhou L; Zhang ZH; Cao W; Wu Q Int J Nanomedicine; 2012; 7():4581-91. PubMed ID: 22942642 [TBL] [Abstract][Full Text] [Related]
6. Improving intestinal absorption and oral bioavailability of curcumin via taurocholic acid-modified nanostructured lipid carriers. Tian C; Asghar S; Wu Y; Chen Z; Jin X; Yin L; Huang L; Ping Q; Xiao Y Int J Nanomedicine; 2017; 12():7897-7911. PubMed ID: 29138557 [TBL] [Abstract][Full Text] [Related]
7. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol. Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044 [TBL] [Abstract][Full Text] [Related]
8. Preparation of Ergosterol-Loaded Nanostructured Lipid Carriers for Enhancing Oral Bioavailability and Antidiabetic Nephropathy Effects. Dong Z; Iqbal S; Zhao Z AAPS PharmSciTech; 2020 Jan; 21(2):64. PubMed ID: 31932990 [TBL] [Abstract][Full Text] [Related]
9. Nanostructured lipid carriers used for oral delivery of oridonin: an effect of ligand modification on absorption. Zhou X; Zhang X; Ye Y; Zhang T; Wang H; Ma Z; Wu B Int J Pharm; 2015 Feb; 479(2):391-8. PubMed ID: 25556104 [TBL] [Abstract][Full Text] [Related]
10. Selenium nanoparticles as versatile carriers for oral delivery of insulin: Insight into the synergic antidiabetic effect and mechanism. Deng W; Xie Q; Wang H; Ma Z; Wu B; Zhang X Nanomedicine; 2017 Aug; 13(6):1965-1974. PubMed ID: 28539272 [TBL] [Abstract][Full Text] [Related]
11. Development of novel rosuvastatin nanostructured lipid carriers for oral delivery in an animal model. Li J; Yang M; Xu W Drug Des Devel Ther; 2018; 12():2241-2248. PubMed ID: 30050285 [TBL] [Abstract][Full Text] [Related]
12. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability. Zhaojie M; Ming Z; Shengnan W; Xiaojia B; Hatch GM; Jingkai G; Li C Int J Pharm; 2014 Jun; 467(1-2):50-9. PubMed ID: 24607213 [TBL] [Abstract][Full Text] [Related]
13. Nanostructured lipid carriers as oral delivery systems for improving oral bioavailability of nintedanib by promoting intestinal absorption. Zhu Y; Liang X; Lu C; Kong Y; Tang X; Zhang Y; Yin T; Gou J; Wang Y; He H Int J Pharm; 2020 Aug; 586():119569. PubMed ID: 32592899 [TBL] [Abstract][Full Text] [Related]
14. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation. Dudhipala N; Janga KY; Gorre T Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077 [TBL] [Abstract][Full Text] [Related]
15. Cysteine-Functionalized Nanostructured Lipid Carriers for Oral Delivery of Docetaxel: A Permeability and Pharmacokinetic Study. Fang G; Tang B; Chao Y; Xu H; Gou J; Zhang Y; Xu H; Tang X Mol Pharm; 2015 Jul; 12(7):2384-95. PubMed ID: 25974386 [TBL] [Abstract][Full Text] [Related]
16. Formulation design, characterization, and in vitro and in vivo evaluation of nanostructured lipid carriers containing a bile salt for oral delivery of gypenosides. Yang G; Wu F; Chen M; Jin J; Wang R; Yuan Y Int J Nanomedicine; 2019; 14():2267-2280. PubMed ID: 31015758 [TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid-coated cationic nanostructured lipid carriers for oral vincristine sulfate delivery. Gao X; Zhang J; Xu Q; Huang Z; Wang Y; Shen Q Drug Dev Ind Pharm; 2017 Apr; 43(4):661-667. PubMed ID: 28043185 [TBL] [Abstract][Full Text] [Related]
18. Berberine loaded nanostructured lipid carrier for Alzheimer's disease: Design, statistical optimization and enhanced in vivo performance. Raju M; Kunde SS; Auti ST; Kulkarni YA; Wairkar S Life Sci; 2021 Nov; 285():119990. PubMed ID: 34592234 [TBL] [Abstract][Full Text] [Related]
19. Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin. Liu Y; Wang L; Zhao Y; He M; Zhang X; Niu M; Feng N Int J Pharm; 2014 Dec; 476(1-2):169-77. PubMed ID: 25280882 [TBL] [Abstract][Full Text] [Related]
20. Repaglinide-loaded nanostructured lipid carriers with different particle sizes for improving oral absorption: preparation, characterization, pharmacokinetics, and Wu L; Zhao L; Su X; Zhang P; Ling G Drug Deliv; 2020 Dec; 27(1):400-409. PubMed ID: 31729898 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]